Recovery Tuesday: Treating Acute & Chronic Pain with LumaCare Duo
Whether treating chronic pain or as part of your acute pain therapy plan, LumaCare makes treatment easily affordable and accessible. LumaCare laser therapy can help alleviate pain’s debilitating impact on your everyday life.
LumaCare acute pain treatment can help boost blood flow and oxygenation for acute pain management. Conversely, pain medications mask symptoms and have been shown to decrease oxygen saturation.
Chronic pain from cartilage loss, arthritis, injury, etc., can be treated easily with the flexible LumaCare Duo. It’s uniquely designed to target the source of pain with 2-8 times more coverage than other LLLT devices. Treating chronic pain with cold laser therapy can reduce inflammation and improve cellular recovery.
About LUMACARE DUO
National Laser began manufacturing lasers in 1987. We are proud to be one of the largest USA laser manufacturing companies.
We pioneered the replacement ion laser tube program for high-speed laser printing, semiconductor mask plotter, and color separation equipment. We also provide a variety of lasers to manufacturers of DNA analysis, cell sorting, confocal microscope, and semiconductor wafer inspection equipment worldwide.
National Laser established a commitment to product reliability and longevity from the beginning.
To meet the expanding requirements of our customers, we developed a new type of Cold Laser system – one designed to maximize treatment effectiveness and improve patient outcomes.
A new brand and division of National Laser, LumaCare Lasers, was developed, creating an ultra pulsed therapeutic laser system: the LumaCare Duo.
These powerful lasers are pulsed so the energy can penetrate the surface of the skin without burning or damaging it.
The LumaCare Duo is the first patented, FDA registered, articulating, dual head, therapeutic laser in its class. It is lightweight, easy to use, and very portable. The perfect size to take anywhere.
Mike Weild, ATC
Territory Sales Manager
Leave a Reply Cancel reply